NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 389.90K | 10.90K | 35.20K | 124.00K | 86.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 389.90K | 10.90K | 35.20K | 124.00K | 86.30K |
| Cost of Revenue | 198.20K | 4.20K | 15.60K | 78.60K | 31.70K |
| Gross Profit | 191.70K | 6.70K | 19.50K | 45.30K | 54.70K |
| SG&A Expenses | 1.64M | 381.60K | 992.50K | 1.55M | 1.48M |
| Depreciation & Amortization | 114.00K | 116.80K | 127.80K | 112.20K | 133.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.95M | 502.70K | 1.14M | 1.74M | 1.65M |
| Operating Income | -1.56M | -491.80K | -1.10M | -1.61M | -1.56M |
| Income Before Tax | -2.16M | -694.90K | -1.35M | -1.87M | -1.70M |
| Income Tax Expenses | 7.90K | -- | -- | 18.70K | 500.00 |
| Earnings from Continuing Operations | -2.17M | -694.90K | -1.35M | -1.89M | -1.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.17M | -694.90K | -1.35M | -1.89M | -1.70M |
| EBIT | -1.56M | -491.80K | -1.10M | -1.61M | -1.56M |
| EBITDA | -1.45M | -379.70K | -987.30K | -1.50M | -1.43M |
| EPS Basic | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 217.32M | 215.88M | 204.98M | 199.13M | 184.59M |
| Average Diluted Shares Outstanding | 217.32M | 215.88M | 204.98M | 199.13M | 184.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |